Cancer is a terrible disease that affects 40% of adults in the United States. Many people know someone whether a family member or friend that has suffered from some type of cancer. Companies such as Tempus are making remarkable strides in helping combat cancer through medicine. Businessman Eric Lefkofsky became frustrated after his wife was diagnosed with breast cancer. He realized that the digital technology and data collections systems were flawed. He decided to co-found a company called Tempus with one goal in mind. They wanted to develop an analytics software that analyzes a cancer patient’s molecular and clinical data. The advanced software includes language processing that also has optical character recognition. The vital information collected can then be transformed into precise data that can be recorded to help advance cancer care and treatment and read full article.
Molecular data is genomic information that is collected through human genome sequencing. This is not something that Tempus discovered, it has been around for a long time. It 2003 it was first mapped and cost around $100 million. With current advances in technology, it can now be accomplished for only $5,000. With the technology that Tempus has brought forth, the cost will only continue to decrease. Erick Lefkofsky and Tempus are determined to continue their advanced work to help find a cure for diseases such as cancer. Through the Tempus platform, doctors will be able to provide cancer patients with the most accurate and effective treatments. Physicians will no longer waste time with treatments that simply do not work. Potentially more then thousands of lives will be saved and what Eric knows.
Eric Lefkofsky was born in 1969 and raised in Southfield, Michigan. He graduated from the University of Michigan with honors in 1991. Later, her received the Juris Doctor degree from the University of Michigan. Eric likes to spend most of his time in Chicago which is where Tempus is headquartered. He is a busy mane serving as board of director for the Lurie’s Children’s Memorial Hospital, the Art Institute of Chicago and the Steppenwolf Theatre Company.